Clarity Pharmaceuticals Limited

Australie


 
Quantité totale PI 46
Rang # Quantité totale PI 30 446
Note d'activité PI 2,6/5.0    49
Rang # Activité PI 15 073
Symbole boursier CU6 (asx)
ISIN AU0000165375
Capitalisation 1.8000001B  (AUD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

25 6
3 0
12 0
0
 
Dernier brevet 2025 - Radiopharmaceuticals, radioimagi...
Premier brevet 2009 - Nitrogen-containing macrocyclic ...
Dernière marque 2024 - CLARITY PHARMACEUTICALS
Première marque 2024 - CLARITY PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Radiopharmaceuticals, radioimaging agents, and uses thereof. The present invention relates to co...
P/S Retail store services featuring pharmaceuticals, pharmaceutical preparations and supplements, med...
P/S Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for the treatme...
P/S Pharmaceuticals and other preparations for medical and veterinary purposes, namely, radioactive p...
Invention Methods for the diagnosis and/or treatment of neuroendocrine cancers. The present invention relat...
Invention Methods for the diagnosis and/or treatment of prostate cancer. The present invention relates gene...
Invention Targeting compounds and methods for their production. The present invention is directed to sarco...
Invention Methods for the detection and diagnosis of cancers associated with overexpression of a psma recep...
Invention Formulations for radiotherapy and diagnostic imaging. The present invention relates to formulati...
2023 Invention Compounds for radioimaging and treatment of a cancer. The present invention relates to compounds ...
Invention Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals. The present invention relate...
Invention Identification and/or treatment of cancer. The present invention relates generally to the identif...
Invention Formulations for radiotherapy and diagnostic imaging and use thereof in treatment, diagnosis and ...
Invention Dimeric radiopharmaceuticals, compositions thereof and uses thereof. The present invention relate...
Invention Radiopharmaceuticals, radioimaging agents, and uses thereof. The present invention relates to com...
Invention Formulations and kits for radiotherapy and diagnostic imaging. Aqueous formulations and kits of ...
2022 Invention Compounds and compositions thereof for the treatment of cancer. The present invention relates to...
Invention Compounds and compositions thereof for the treatment of cancer. The present invention relates to ...
Invention Radiopharmaceuticals, methods for the production thereof, and uses in treatment, diagnosis and im...
2021 Invention Radiopharmaceuticals, uses thereof, and methods for the production thereof. Radiopharmaceutical ...
Invention Radiopharmaceuticals, uses thereof, and methods for the production thereof. Radiopharmaceutical c...
Invention Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals. The present invention relates...
2020 Invention Radiolabelled targeting ligands. The present invention relates to compounds that are useful as r...
Invention Radiolabelled targeting ligands. The present invention relates to compounds that are useful as ra...
Invention Formulations of psma imaging agents. The present invention relates to formulations of radiolabel...
Invention Formulations of psma imaging agents. The present invention relates to formulations of radiolabele...
2019 Invention Targeting compounds and methods for their production. The present invention is directed to sarcop...
Invention Formulations and kits for radiotherapy and diagnostic imaging. Aqueous formulations and kits of r...
2017 Invention Formulations for radiotherapy and diagnostic imaging. The present invention relates to stable for...
2016 Invention Cage amine ligands for metallo-radiopharmaceuticals. The present invention relates to compounds t...
2012 Invention Functionalisation of cage amine ligands for metallo-radiopharmaceuticals. The present invention r...